D
TScan Therapeutics, Inc. TCRX
$1.82 $0.084.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -42.94% -70.15% -86.62% -44.71% -25.65%
Total Other Revenue -- -- -- -- --
Total Revenue -42.94% -70.15% -86.62% -44.71% -25.65%
Cost of Revenue 33.87% 64.21% 68.50% -81.41% -84.24%
Gross Profit -1,538.42% -160.47% -111.17% 91.05% 101.04%
SG&A Expenses 23.22% 24.03% 14.92% 7.95% 6.17%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.14% 23.28% 20.20% 19.64% 25.06%
Operating Income -29.25% -36.84% -44.26% -31.64% -35.13%
Income Before Tax -30.99% -35.83% -42.91% -26.01% -27.99%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -30.99% -35.83% -42.91% -26.01% -27.99%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -30.99% -35.83% -42.91% -26.01% -27.99%
EBIT -29.25% -36.84% -44.26% -31.64% -35.13%
EBITDA -32.32% -40.42% -48.37% -34.75% -38.42%
EPS Basic -15.53% -17.97% -3.80% 18.58% 26.78%
Normalized Basic EPS -14.62% -17.01% -2.98% 18.58% 26.78%
EPS Diluted -15.53% -17.97% -3.80% 18.58% 26.78%
Normalized Diluted EPS -14.62% -17.01% -2.98% 18.58% 26.78%
Average Basic Shares Outstanding 13.64% 15.05% 26.15% 40.94% 64.31%
Average Diluted Shares Outstanding 13.64% 15.05% 26.15% 40.94% 64.31%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --